Последно актуализиране :
03/05/2024
противораково лекарство   Thiotepa  
Инжекция/Инжекционен
Стабилност на разтвори Стабилност на смеси Фактори, повлияващи стабилността Съвместимост Път на въвеждане Библиография Pdf
   Химична структура  

Търговско наименование   Търговско наименование     

Търговските имена са примерни и съставът на помощните вещества може да бъде различен в зависимост от държавата и лабораториите

Bedford нова Зеландия
Ledertepa Холандия
Oncotiotepa Испания
Thioplex Италия
Thiotepa Австралия, Австрия, Великобритания, Германия, Ирландия, Съединени Американски щати / САЩ, Швеция
Библиография   Инжекция/Инжекционен   Библиография : Thiotepa  
Вид Публикация
3 Списание Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
81 Списание Trissel LA, Martinez JF.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 672-678.
84 Списание Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499.
99 Списание Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
169 Списание Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
182 Списание Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
244 Списание Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
249 Списание Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
302 Списание Murray KM, Erkkila D, Gombotz WR, Pankey S.
Stability of thiotepa (lyophilized) in 0.9% sodium chloride injection.
Am J Health-Syst Pharm 1997 ; 54: 2588-2591.
307 Списание Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799.
905 Списание Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017.
1410 Списание Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1423 Списание Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
3603 Лаборатория Thiotepa (Tepadina®) - Summary of Product Characteristics
Adienne Pharma Biotech 2011
4677 Плакат Linxweiler H, Thiesen J, Krämer I.
Physicochemical stability of diluted "Thiotepa Riemser" infusion solutions in prefilled 5% glucose infusion bags.
EAHP Congress Vienna 2022
4748 Списание Linxweiler H, Thiesen J, Krämer I.
Physicochemical Stability of Generic Thiotepa Concentrate and Ready-to-Administer Infusion Solutions for Conditioning Treatment.
Pharmaceutics 2023 ,15, 309.

  Mentions Légales